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Abstract
Background: Recent work by our laboratory and others has implicated NADPH oxidase as having an important role in
reactive oxygen species (ROS) generation and neuronal damage following cerebral ischemia, although the mechanisms
controlling NADPH oxidase in the brain remain poorly understood. The purpose of the current study was to examine the
regulatory and functional role of the Rho GTPase, Rac1 in NADPH oxidase activation, ROS generation and neuronal cell
death/cognitive dysfunction following global cerebral ischemia in the male rat.
Methodology/Principal Findings: Our studies revealed that NADPH oxidase activity and superoxide (O2
2) production in the
hippocampal CA1 region increased rapidly after cerebral ischemia to reach a peak at 3 h post-reperfusion, followed by a fall
in levels by 24 h post-reperfusion. Administration of a Rac GTPase inhibitor (NSC23766) 15 min before cerebral ischemia
significantly attenuated NADPH oxidase activation and O2
2 production at 3 h after stroke as compared to vehicle-treated
controls. NSC23766 also attenuated ‘‘in situ’’ O2
2 production in the hippocampus after ischemia/reperfusion, as determined
by fluorescent oxidized hydroethidine staining. Oxidative stress damage in the hippocampal CA1 after ischemia/reperfusion
was also significantly attenuated by NSC23766 treatment, as evidenced by a marked attenuation of immunostaining for the
oxidative stress damage markers, 4-HNE, 8-OHdG and H2AX at 24 h in the hippocampal CA1 region following cerebral
ischemia. In addition, Morris Water maze testing revealed that Rac GTPase inhibition after ischemic injury significantly
improved hippocampal-dependent memory and cognitive spatial abilities at 7–9 d post reperfusion as compared to vehicle-
treated animals.
Conclusions/Significance: The results of the study suggest that Rac1 GTPase has a critical role in mediating ischemia/
reperfusion injury-induced NADPH oxidase activation, ROS generation and oxidative stress in the hippocampal CA1 region
of the rat, and thus contributes significantly to neuronal degeneration and cognitive dysfunction following cerebral
ischemia.
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Introduction
Ischemic stroke is a significant clinical problem of complex
neuropathology, and is the third leading cause of death in the
United States of America. Abundant evidence suggests that
oxidative stress contributes significantly to the neuronal cell death
that occurs following ischemic stroke. For instance, following
reperfusion of the brain, there is a rapid increase of reactive
oxygen species (ROS) and reactive nitrogen species (RNS), which
has been shown to result in increased lipid peroxidation, protein
nitrosylation, DNA damage and blood brain barrier dysfunction,
thereby contributing to neuronal cell death [1–3]. It has been
previously suggested that mitochondria are a primary source of
ROS following ischemic reperfusion [4,5]. Recently however,
there is emerging evidence that a membrane enzyme, NADPH
oxidase, contributes significantly to ROS generation following
ischemic reperfusion [6–8]. Activation of NADPH oxidase leads to
generation of the superoxide ion (O2
2), a ROS which can be
converted to the highly reactive hydroxyl radical and to
peroxynitrite, a highly damaging RNS [2,8]. To date, five
NADPH oxidase enzyme (NOX) isoforms have been identified
(NOX 1–5), and localization studies have shown that of the five
NOX enzymes, the NOX2 and NOX4 isoforms are highly
localized in the hippocampus CA1 and cerebral cortex [9,10].
NOX2 appears particularly important in oxidative stress-induced
neuronal cell death following stroke, as evidenced by a dramatic
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NOX2 inhibitor-treated animals [12].
The factors that regulate brain NOX2 NADPH oxidase
activation are not well understood. Studies in immune cells have
provided evidence that the Rho GTPase, Rac1, plays an
important role in NOX2 activation in immune cells. Upon
cellular stress, Rac dissociates from its cytosolic complex with
guanosine diphosphate (GDP) dissociation inhibitor (GDI). The
inactive Rac-GDP is then exchanged for GTP through the action
of guanine nucleotide exchange factors (GEFs), Tiam1 and Trio,
which are located on the membrane. Once active, Rac-GTP
associates with the membrane and interacts with the tetratricopep-
tide repeat (TPR) site on p67phox subunit [13] and with
membrane bound NOX2, resulting in NADPH oxidase complex
activation [14,15]. Surprisingly, there is not much known on the
role of Rac1 GTPase in the ischemic brain. Work from our group
has shown that administration of the Rac GTPase inhibitor
(NSC23766) decreases activation of the proapoptotic signaling
kinase, JNK in the hippocampus CA1 region following ischemic
stroke reperfusion and reduces apoptosis [7]. Furthermore, the
hormone estrogen was shown to suppress Rac1 GTPase activation
in the hippocampus following ischemic stroke as a component of
its neuroprotective actions [12]. It is currently unknown whether
Rac1 GTPase plays an important role in NADPH oxidase
activation, ROS generation and oxidative stress in the hippocam-
pus following stroke, and whether inhibition of Rac GTPase
activation might preserve cognitive function following cerebral
ischemia. The current study addressed these important questions
using a 4-vessel global cerebral ischemia rat model, which induces
significant damage to the hippocampus CA1 region, an area
critical for memory and cognitive function.
Methods
Induction of global cerebral ischemia
The experimental model of global cerebral ischemia (GCI) has
been widely used to study delayed neuronal cell death of sensitive
hippocampus CA1 pyramidal neurons, which occurs 2–4 days
after the onset of reperfusion [16]. In the current study, three-
month old adult male Sprague–Dawley rats were used and GCI
was induced by four-vessel occlusion, as described previously
[17,18]. Briefly, under anesthesia with chloral hydrate (350 mg/
kg, i.p.), the vertebral arteries were electrocauterized and the
common carotid arteries (CCA) were exposed. Wound clips were
used to close the incision and the rats were allowed a 24 h
recovery period. After 24 h, the animals were anesthetized using
3% isoflurane anesthesia and the CCA were re-exposed and
clipped via aneurysm clips. A 10-min occlusion period was used
for the GCI. Rats which lost their righting reflex within 30 sec and
whose pupils were dilated and unresponsive to light during
ischemia were selected for the experiments. Carotid artery blood
flow was restored by releasing the clips allowing reperfusion.
Rectal temperature was maintained at 37u Celsius using a thermal
blanket throughout the experiment and 2 h post-ischemia. Sham
controls underwent the same surgical exposure procedures, except
that the arteries were not occluded. All procedures were approved
by the Medical College of Georgia institutional committee for care
and use of animals (#07-04-932) and were in accordance with
National Institutes of Health guidelines.
Histology analysis
Histological examination of the ischemic brain was performed
by neuronal-specific nuclear protein (NeuN) and the neuronal
degeneration marker (Fluoro-Jade B), as described previously by
our laboratory [19]. Briefly, after perfusion with 0.9% saline
followed by 4% paraformaldehyde (PFA) in 0.1 M phosphate
buffer, the brains were post-fixed, cryoprotected with 30% sucrose
until they sank, and frozen sectioned (20 mm) in the coronal plane
of the dorsal hippocampus (,2.5–4.5 mm posterior from bregma).
Every fifth section was collected and used for staining. Staining for
NeuN and Fluoro-Jade B was performed using a mouse anti-NeuN
monoclonal antibody (1:500; Millipore, Billerica, MA USA) and
Fluoro-Jade B (AG310; Millipore). Images were captured on an
LSM510 Meta confocal laser microscope (Carl Zeiss, Peabody,
MA USA). Cells that positively stained with NeuN and negatively
stained with Fluoro-Jade B were identified as ‘‘surviving neurons’’;
in contrast, double-stained yellow-colored cells represent CA1
neurons undergoing degeneration.
TUNEL staining
Terminal deoxynucleotidyl transferase-mediated biotinylated
UTP nick end (TUNEL) staining was performed on the free-
floating coronal sections using the In Situ Cell Death Detection kit
(Roche, Basel, Switzerland) following the instructions of the
manufacturer. Briefly, after washing with 0.1% PBS–Triton X-
100, the slides were permeabilized with 10 mg/mL proteinase K in
10 mM Tris/HCl, pH 7.4, for 15 min and incubated with
TUNEL reaction mixture, including enzyme solution (terminal
deoxynucleotidyl transferase) and tetramethylrhodamine-labeled
TUNEL-positive nucleotides in a humidified chamber for 1 h at
37u Celsius. Slides for negative control were incubated with the
label solution without terminal transferase for TUNEL. Samples
were analyzed with a LSM510 Meta confocal microscope. For
quantitative analyses, the number of surviving neurons and
TUNEL-positive cells per 250 mm length of medial CA1
pyramidal cell layer were counted bilaterally in four to five
sections per animal to provide a single value for each animal. A
mean 6SE was calculated from the data in each group, and
statistical analysis was performed as described below.
DAB staining
For DAB staining, sections were incubated with 10% normal
donkey serum in PBS containing 0.1% Triton X-100 and 0.3%
H2O2 for 1 h at room temperature to block nonspecific surfaces.
Sections were then incubated with the primary antibodies
overnight at 4u Celsius in PBS containing 0.1% Triton X-100.
The antibodies used were as follows: mouse anti-4-hydroxy-2-
nonenal (4-HNE) (1:500; Genox, Baltimore, MD USA), mouse
anti-8-hydroxy-29-deoxyguanosine (8-OHdG) (1:100; Genox),
rabbit anti-p-H2A.X (1:200; Cell Signaling Technology, Danvers,
MA USA). Afterwards, sections were washed with the same buffer,
followed by incubation with secondary biotinylated goat anti-
mouse or goat anti-rabbit antibodies (Vector Laboratories,
Burlingame, CA USA) at a dilution of 1:200 in PBS containing
0.1% Triton X-100 for 1 h at room temperature. Sections were
then washed, followed by incubation with ABC reagents for 1 h at
room temperature in the same buffer. Sections were rinsed in the
same buffer and incubated with DAB reagent according to the
instructions of the manufacturer (Vector Laboratories) for 2–
10 min. After DAB incubation, sections were briefly washed with
distilled water and dehydrated in graded alcohols, cleared in
xylene, and mounted using xylene-based mounting medium.
Images were captured on an Axiophot-2 visible/fluorescence
microscope using an AxioVision4Ac software system (Carl Zeiss).
Confocal microscopy and image analysis
Images were captured on an LSM510 Meta confocal laser
microscope (Carl Zeiss) using either a 5X or 40X oil-immersion
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at 102461024 pixels. The following excitation/emission laser filter
settings were used for various chromophores: an argon/2 laser was
used for Alexa-Fluor488, with excitation maximum at 490 nm and
emission in the range of 505–530 nm, a helium–neon laser was
used for Alexa-Fluor594 with excitation maximum at 543 nm and
emission in the range of 568–615 nm, and a second helium–neon
laser was used for Alexa-Fluor647 with excitation maximum at
633 nm and emission in the range of 650–800 nm. The captured
images were viewed and analyzed using LSM510 Meta imaging
software as previously described [20].
In situ detection of superoxide production
The production of superoxide (O2
2) free radicals was
investigated using hydroethidine (HEt) (Invitrogen, Carlsbad, CA
USA) as described previously by our group and others [12,20,21].
In the present study, HEt (1 mg/ml in 200 ml of PBS) was
administered intravenously 30 min before ischemia. Animals were
anesthetized using isoflurane 3 h after ischemia and transcardially
perfused with cold PBS and 4% PFA. Sham non-ischemic control
animals were also treated with HEt solution as O2
2 production
control. Fluorescent intensity of the oxidized HEt was measured
on a confocal laser microscope using an excitation wavelength of
543 nm, and the emission was recorded at wavelengths between
560 and 590 nm. The images were then examined using LSM 510
image software.
Brain Homogenates
For brain tissue preparation, rats were sacrificed under
isoflurane anesthesia at 30 min, 3 h, 6 h and 24 h after GCI.
The hippocampal CA1 region was micro-dissected from both sides
of the hippocampal fissure and immediately frozen in liquid
nitrogen. Tissues were homogenized with a Teflon-glass homog-
enizer in ice cold homogenization medium consisting of 50 mM
HEPES (pH 7.4), 150 mM NaCl, 12 mM b-glycerophosphate,
3 mM dithiotheitol (DTT), 2 mM sodium orthovanadate
(Na3VO4), 1 mM EGTA, 1 mM NaF, 1 mM phenylmethylsulfo-
nyl fluoride (PMSF), 1% Triton X-100, and 10 mg/ml each of
aprotinin, leupeptin, and pepstatin A. The homogenates were
centrifuged at 15,000 6g for 30 min at 4u Celsius, supernatants
were collected and stored at 280u Celsius for use. The protein
concentrations were determined by a Lowry protein assay kit with
bovine serum albumin as standard.
NADPH oxidase activity and superoxide production assay
NADPH oxidase activity was determined based on superoxide-
induced lucigenin photoemissions, as described previously by our
laboratory [12]. For assaying NADPH oxidase enzymatic activity,
50 mg of total fraction was used. Enzyme assays were performed in
a final volume of 1 ml containing 50 mMKrebs’–Ringer’s
phosphate buffer, pH 7.0, 1 mM EGTA, 150 mM sucrose,
0.5 mM lucigenin, 0.1 mM NADPH, and tissue homogenate.
Enzyme reactions were initiated with the addition of NADPH. No
enzymatic activity could be detected in the absence of NADPH.
Photoemissions, expressed in terms of relative light units (RLU),
were measured every min for 5 min using a luminometer. Assays
were performed in the dark at room temperature with appropriate
controls. The rate of NADPH consumption was monitored by
measuring the mean values in absorbance (340 nm), and NADPH
oxidase activity was normalized by the amount of protein and the
change in optical density (OD). Activity was calculated as OD per
micrograms of protein per minute. Superoxide production was
measured from total fractions using a LumiMax Superoxide Anion
Detection kit (Stratagene, La Jolla, CA USA) following the
protocol of the manufacturer. Briefly, 50 mg of sample protein was
suspended in 100 ml of superoxide anion (SOA) assay medium and
then mixed with 100 ml of reagent mixture containing 0.2 mM
luminol and 0.25 mM enhancer in SOA assay medium. Light
emissions at 30 sec intervals were recorded by a standard
luminometer and absorbance was measured at 340 nm. Values
were standardized to the amount of protein, and photons of light
counted were expressed as RLU per microgram of protein. A
mean 6SE was calculated from the data collected in each group
for graphical depiction, expressed as fold change vs. sham control
group. Statistical analysis of the data was performed as described
below.
Rac1-GTP binding assay
Rac1 activation assay was performed using PAK1-PBD color
agarose beads (Cell Biolabs). Briefly, 400 mg samples were mixed
with 20 ml of PAK1-PBD agarose beads and incubated for 1 h at
4u Celsius. The reaction was terminated by addition of MgCl2.
The agarose beads were collected by spinning at 12,0006g for
1 min at 4u Celsius and the supernatants removed. Precipitated
complexes were washed three times with magnesium-containing
TBS buffer and boiled in sample buffer. Proteins were separated
by 10% SDS-PAGE, transferred onto nitrocellulose membrane,
and detected by immunoblotting using an anti-Rac1-specific
antibody (1:1000, BD Biosciences Transduction Laboratories).
Intracerebroventricular administration
To investigate the role of Rac1 GTPase in response to ischemic
injury, 25 mg of the Rac inhibitor, NSC23766 (Tocris Bioscience,
Ellisville, Missouri, USA), was dissolved in 5 mL saline and
administered bilaterally into the lateral cerebral ventricles of rats
15 min before ischemia for a total dose of 50 mg. Vehicle-treated
control animals received bilateral saline injections. The 50 mg dose
of the inhibitor was chosen based on a previous dose response
curve performed in our lab which showed it to be the most optimal
and effective dose in inhibiting Rac GTPase activation in the
hippocampal CA1 region following intracerebroventricular (icv)
injection, and which did not display any significant behavioral side
effects [7]. To investigate the role of NOX2 NADPH oxidase, we
utilized a specific competitive NOX2 inhibitor, gp91ds-tat, which
is a 9 amino acid peptide sequence of the p47Phox docking site on
NOX2 and prevents p47phox from forming a complex with
NOX2 [22]. A scrambled gp91ds-tat peptide was used as a
control. Gp91ds-tat and the scrambled peptide control was
administered bilaterally via icv injection in the lateral ventricles
at a dose of 100 ng in 5 ml. The dose of gp91ds-tat was chosen
based on previous studies by our laboratory showing its
effectiveness and lack of side effects [12]. For i.c.v. injections,
the rats were placed on ear bars of a stereotaxic instrument under
anesthesia. Drug infusion was performed using a steppermotorized
microsyringe (Stoelting, Wood Dale, IL, USA) at a rate of 1 mL/
min through a pre-implanted cannula in the cerebral ventricle
(from the bregma: anteroposterior, 60.8 mm; lateral, 1.5 mm;
depth, 3.5 mm).
Morris Water Maze
Rats were randomly assigned to the following groups: sham
operated group (sham), NSC23766-treated sham group, ischemia/
reperfusion group (I/R), NSC23766-treated group and I/R+ve-
hicle group. On the 7
th day after ischemia onset, the Morris water
maze test was performed to test spatial learning and memory as
described previously by our laboratory and others [23–25]. The
maze consisted of a black circular pool (diameter 2.14 m, height
80 cm, filled with water at 21–22u Celsius to a height of 50 cm). A
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the water line in the center of one quadrant, and remained in the
same position. Several, constant, large visual cues surrounded the
tank at a height of 120–150 cm to facilitate orientation. The rat
was placed in the water facing the wall at one random start
location out of four (north, south, east and west), located
equidistance from one another around the rim of the pool. Each
rat was then allowed to find the submerged platform within 90 sec,
and rest on it for 20 sec. If the rat failed to find the hidden
platform within allotted time, it was placed on it for 20 sec. The
procedure was repeated for all the four start locations. The latency
time, representing the average of the four trails to reach the
platform and swimming speed were recorded. Two sessions of the
four trails were conducted on the first testing day, within a 4 h
interval. The first session was considered as a training procedure.
One session out of the four trails was conducted daily on the next 2
testing days. Four hours after the last trail, a probe trail was
performed within 90 sec, in which the platform was removed from
the tank. The rat was placed in the water at the same random start
location, and time spent in the quadrant of the pool, which
previously contained the platform, was recorded. The test assessed
how well the rats remembered the location of the hidden platform
and whether the rats had a learned bias to navigate toward the
goal quadrant.
Statistical evaluation
Four to five animals were used per group. All values were
expressed as the means 6SE. Statistical analysis of the results was
carried out by one-way analysis of variance (ANOVA) followed by
the Student-Newman–Keuls test. Statistical significance was
accepted at the 95% confidence level. Differences of p,0.05
were considered significant.
Results
Rac1 GTPase activation contributes significantly to
delayed neuronal cell degeneration in the hippocampus
CA1 region following GCI
Figure 1 shows the results of the effect of administration of a
Rac GTPase inhibitor, NSC23766 upon Rac1 GTPase activity
(Fig. 1A) and neuronal cell survival (Fig. 1B&C) in the
hippocampal CA1 region. As shown in Figure 1A, a PAK1
substrate was used to pull down active, GTP-bound Rac1 via its
PBD domain, in order to examine Rac1 activity in total CA1
lysates at 3 h following ischemia/reperfusion. Our results show
low, baseline Rac1 activity levels in sham non-ischemic animals,
while there was a robust elevation of Rac1 activity in ischemic
animals at 3 h post-reperfusion (R3h). Furthermore, saline
treatment had no effect upon Rac1 activity at 3 h post-reperfusion,
whereas treatment with the Rac GTPase inhibitor, NSC23766
resulted in ,50% reduction in Rac1 activity as compared to
controls. Note that total Rac1 protein expression was unchanged
by any treatment. Data was reported in fold change versus sham,
in 4–5 animals per treatment group. Taken altogether, our
findings suggest NSC23766 to be an effective Rac1 inhibitor,
having the ability to counteract Rac1 activation at 3 h following
cerebral ischemia. Figure 1B shows that NSC23766 pretreatment
significantly protected against delayed neuronal cell degeneration
and death in the hippocampal CA1 region at 7 d after GCI.
Representative photomicrographs of stained hippocampal CA1
Figure 1. Rac GTPase Activation Contributes Significantly to Neuronal Cell Death in the Hippocampus CA1 Region Following Global
Cerebral Ischemia (GCI). (A) NSC23766 significantly attenuated cerebral ischemia-induced Rac1 activity at 3 h after ischemia. *Represents P,0.05
(four to 5 animals) vs. reperfusion 3 hour (R3h) and saline treatment groups. (B) Representative hippocampal CA1 sections from sham, saline–treated
(ischemia) and NSC23766-treated (ischemia) male rats were labeled with NeuN (Blue), TUNEL (Red) and FJadeB (Green) staining at 7 d following GCI.
Merged images represent CA1 neurons undergoing degeneration, indicated by white staining. (C) Quantification showed that NSC23766 was
strongly neuroprotective of CA1 region. Data was obtained from five independent animals and a typical experiment is presented. Results are
expressed as neuronal density with mean 6 SE.
*p,0.05 vs. sham control and NSC23766.
doi:10.1371/journal.pone.0012606.g001
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hippocampal CA1 neurons at 7 d following ischemic reperfusion,
as indicated by a significant decrease in NeuN-positive stained cells
in saline-treated animals following GCI as compared to sham
controls (Fig. 1B). In addition, there was a significant increase in
staining for Fluoro-Jade B (a neurodegeneration marker) and
TUNEL (a method for detecting apoptosis) in the hippocampal
CA1 region in saline-treated (ischemia) animals as compared to
sham controls, which suggests there is increased neuronal
degeneration and apoptosis following ischemic reperfusion.
Merged, colocalized images of the hippocampus CA1 further
demonstrate that the Fluoro-Jade B and TUNEL staining is
predominantly neuron-specific. Intriguingly, icv administration of
the Rac GTPase inhibitor (NSC23766) strongly protected the
hippocampal CA1 neurons from neuronal degeneration and
apoptotic cell death, as evidenced by preserved NeuN neuronal
staining and strongly attenuated Fluoro-Jade B and TUNEL
staining in NSC23766-treated animals as compared to saline
controls (Figure 1B). In Figure 1C, quantification of staining
results from all animals is provided (expressed in terms of neuronal
density - e.g. number of hippocampal CA1 cells per 250 mm).
Surviving neurons within the hippocampus CA1 are defined as
NeuN-positive and Fluoro-Jade B- and TUNEL-negative stained
cells. The results demonstrate a profound reduction in neuronal
density in vehicle-treated ischemic animals as compared to sham
(non-ischemic) animals. NSC23766 treatment markedly attenuat-
ed hippocampal CA1 neuronal death following GCI, suggesting a
critical role for Rac GTPase activation in delayed neuronal cell
degeneration and death in the hippocampal CA1 region following
GCI.
Temporal pattern of NADPH oxidase activation and
superoxide (O2
2) production in the rat hippocampal CA1
region following GCI
Rac1 GTPase activation has been suggested to be critical for
NADPH oxidase activation in immune cells and may have a
similar role in the brain. To explore this possibility, we first
examined the temporal pattern of NADPH oxidase activation
and O2
2 production in the male rat hippocampal CA1 region
following GCI. As shown in Figure 2A, NADPH oxidase
activation in the hippocampal CA1 region increased rapidly
following ischemic reperfusion, with an elevation observed as
early as 30 min post-reperfusion, and peak NADPH oxidase
activation levels observed at 3 h post-reperfusion (,3 fold
increase versus sham controls). NADPH oxidase activation levels
subsequently fell at 6 h and 24 h after reperfusion, but mean
levels were still higher than sham controls. Similarly, in
Figure 2B,O 2
2 levels showed a similar rapid elevation at
30 min following GCI reperfusion, with peak levels observed at
3 h post-reperfusion (,4-fold increase as compared to sham
controls). Thereafter, O2
2 levels fell slightly at 6 h post-
reperfusion, and by 24 h post-reperfusion, O2
2 levels, while still
moderately elevated, were no longer statistically different from
sham controls.
Rac GTPase activation is critical for enhanced NADPH
oxidase activity and O2
2 production in the hippocampal
CA1 region following GCI
We next examined the role of Rac GTPase activation in
enhanced NADPH oxidase activation and O2
2 production in the
hippocampal CA1 region following GCI by determining the effect
of inhibiting Rac GTPase activation via administration of
NSC23766. NADPH oxidase activation and O2
2 production
were examined at 3 h following ischemia-reperfusion (e.g. the
time-point of peak NADPH oxidase activation and O2
2
production following GCI), and in situ O2
2 production was also
assessed using the in situ oxidized hydroethidine (HEt) method, in
which HEt, a marker of O2
2 production, is selectively taken up by
cells and oxidized by O2
2 into ethidium, which provides a red
fluorescence signal. As shown in Figure 3A–B, treatment with
NSC23766 significantly attenuated the GCI-induced elevation of
NADPH oxidase activation and O2
2 production in the hippo-
campal CA1 region at 3 h after reperfusion. In addition, ‘‘in situ’’
O2
2 production, as measured by oxidized HEt staining, confirmed
increased O2
2 production in the hippocampal CA1 region
following GCI, which was strongly attenuated by the Rac
inhibitor, NSC23766 (Figure 3C).
Contribution of NADPH Oxidase to Ischemic Neuronal
Cell Death at 7d Post-Reperfusion, in the Hippocampal
CA1 Region
To confirm the critical role of NADPH oxidase complex
formation and in GCI-induced neuronal cell death, we injected
male rats with a specific competitive NOX2 inhibitor, gp91ds-tat
(100 ng bilaterally icv, 30 min prior to GCI). In addition, a
Figure 2. Temporal Expression of NADPH Oxidase Activity and Superoxide Production in the Hippocampal CA1 Region Following
GCI. Homogenates taken from the hippocampus CA1 at 30 min, 3 h, 6 h, 24 h after reperfusion were subjected to NADPH oxidase activity (A) and
superoxide production (B) assays to assess temporal expression following ischemia-reperfusion. Data is expressed as optical density (OD) and
represented as fold vs. sham from four to five animals.
*p,0.05 vs. sham control.
doi:10.1371/journal.pone.0012606.g002
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activity was used as a control. Coronal CA1 sections were collected
at 7 d after GCI and stained with NeuN neuronal marker to
determine neuronal survival following GCI. As shown in Fig. 4A,
the results revealed that NeuN staining was high in the
hippocampal CA1 region in sham (non-ischemic) animals
(Fig. 4A, panel a), while ischemia/reperfusion and scrambled-tat
injected control groups (Fig. 4A, panels b,c, respectively) showed a
distinct loss of NeuN-stained neurons in the CA1 region 7 d after
ischemia. In contrast, gp91ds-tat administration exerted significant
neuroprotection, as indicated by preservation of NeuN-positive
neurons in the hippocampal CA1 region (Fig. 4A, panel d).
Quantification of the results is provided in Figure 4B which
demonstrates a neuroprotective effect of gp91ds-tat. As a whole,
these findings suggest that NADPH oxidase activation plays a
significant role in neuronal cell death in the hippocampal CA1
region following GCI.
Inhibition of Rac GTPase activation attenuates induction
of oxidative stress damage in the hippocampus CA1 after
GCI
We next examined the effect of Rac GTPase inhibition upon
oxidative stress damage in the hippocampal CA1 region following
GCI. Immunostaining for the oxidative stress markers, 4-HNE (4-
hydroxynonenal), 8-OHdG (8-hydroxydeoxyguanosine), and p-
H2AX (phospho-histone) was conducted at 24 h after GCI to
assess lipid peroxidation, DNA damage and oxidative histone
phosphorylation, respectively. The results show robust increases in
immunostaining intensity for all three oxidative stress markers in
the saline-injected (ischemia) group as compared to sham controls
(Figure 5). Rac GTPase inhibition through administration of
NSC23766 resulted in an almost complete attenuation of the
oxidative stress damage as indicated by a strong attenuation of 4-
HNE, 8-OHdG and p-H2AX immunostaining in the hippocam-
pal CA1 region as compared to saline (ischemia) controls.
Figure 3. Rac GTPase Activation is Critical for Enhanced NADPH Oxidase Activity and Superoxide Production in the Hippocampal
CA1 Region Following GCI. NSC23766 pre-treatment reduces NADPH oxidase activity (A) and superoxide production (B) at 3 h post-reperfusion in
the hippocampus CA1 after GCI. Data for experiments (A) and (B) was measured as optical density (OD) and expressed as fold difference in
comparison to sham from four to five animals. *p,0.05 vs. sham,
#p,0.05 vs. saline control. HET staining measuring endogenous superoxide
production in CA1 coronal brain sections obtained from four to five animals; magnification 40X (C).
doi:10.1371/journal.pone.0012606.g003
Figure 4. Contributions of NADPH oxidase to Ischemic Neuronal Damage in Hippocampal CA1. (A) Representative staining of coronal
CA1 sections with NeuN (red) show neuroprotection of gp91ds-tat peptide at day 7 after reperfusion. a: Sham; b: Ischemic reperfusion; c: Scrambled
gp91ds-tat control; d: gp91ds-tat (91ds-tat). (B) CA1 neuronal density was counted per 250 mm length of medial CA1 region from five to six rats in
each group. *p,0.05 vs. reperfusion at 7 days (R7d) and Scr treatment groups. Scr: gp91ds-tat control.
doi:10.1371/journal.pone.0012606.g004
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and spatial memory in the hippocampal CA1 region
To determine the functional importance and role of Rac
GTPase activation in cognitive decline following GCI, the
M o r r i sw a t e rm a z et e s tw a su s e dt o assess spatial navigation on a
spatial memory at 7–9 days after ischemic reperfusion. In
Figure 6A and 6B, we first compared sham non-ischemic
animals’ performance in the Morris water maze to that of Rac
inhibitor treated rats at 7 d, 8 d and 9 d post-reperfusion. Both
probe and latency trials failed to show any significant difference
between Rac inhibitor-treated (NSC23766) and vehicle (sham)
control (non-ischemic) animals in locating the hidden platform
or navigating towards the goal quadrant. Furthermore, Fig. 6C
shows that NSC23766 treatment did not affect swimming speed
a t7d ,8da n d9da f t e rG C I .Figure 6D illustrates NSC23766
effects on latency time in finding the hidden platform during
probe trials. There was no significant difference between
ischemic rats (I/R) and saline-injected (Vehicle + I/R) animals
in finding the submerged platform. In contrast, sham-operated
and NSC23766-treated rats’ latency time became progressively
shorter in a day-dependent manner. On day one, both I/R and
vehicle + I/R animals spent a longer time searching for the
hidden platform, as compared to sham. Interestingly,
NSC23766-treated rats exhibited shorter exploration times,
marked by the rapid discovery of the hidden platform’s location,
yet no statistically significant differences were present between
NSC23766 and vehicle-injected animals. On the second testing
day, however, NSC23766-treated animals showed a latency
time to finding the hidden platform similar to sham-operated
rats, and displayed a profoundly shorter latency time as
compared to the vehicle + I/R group. Along the same lines,
the last day of the probed trials revealed a similar pattern, where
rats in sham and NSC23766-treated groups spent a considerably
shorter time in finding the hidden platform than vehicle-treated
group. Representative trace diagrams indicating the latency
time to finding the submerged platform are depicted in
Figure 6F,p a n e l sa ,b ,c ,d .I np r o b et r a i l sc h a r a c t e r i z e db y
the removal of the hidden platform (Figure 6E), ischemic and
vehicle-treated rats displayed worse learned bias navigating
towards the goal quadrant, which previously contained the
platform. They spent less time in the goal quadrant than their
sham counterparts. NSC23766-treated rats, on the other hand,
displayed improved learned bias, as evidenced by spending
more time in the goal quadrant than ischemic animals. In fact,
there was no statistical difference between NSC23766 and sham
animals in the time spent searching for the hidden platform. It
should be added that differences in the swimming speed were
negligible between the various experimental groups (data not
shown, p.0.05). Representative traces obtained during the
specified probed trials are depicted in Figure 6F -e ,f ,g ,h .
Overall, these results suggest that Rac GTPase activation plays
an important pathological role in ischemic stress-induced
cognitive impairment.
Discussion
The current study adds to growing evidence of an important
role of Rac1 GTPase in oxidative stress and neuronal cell death
following cerebral ischemia. Previous work by our group
demonstrated that Rac1 GTPase activation increases from
10 min to 72 h in the hippocampal CA1 region following GCI
in rats, with peak levels from 3 h–6 h post reperfusion [7,12]. The
elevation of Rac GTPase activation appears to contribute to the
pathology following ischemic stress as evidenced by our finding
that administration of a Rac GTPase inhibitor, NSC23766 or
Rac1 antisense oligonucleotides [7] attenuated apoptotic neuronal
cell death following GCI. In addition, the current study revealed
that neuronal degeneration in the hippocampal CA1 region was
also markedly inhibited by the pretreatment of the Rac GTPase
inhibitor following GCI, suggesting an important role of Rac
GTPase activation in delayed neuronal degeneration following
ischemia/reperfusion injury. It should be mentioned that we also
examined post-treatment administration of NSC23766 (15 min.
after ischemia; 25 mg bilaterally i.c.v.) and while we found it to
enhance survival of hippocampal neurons (29.2564.48) as
compared to saline-treated controls (4.2561.25), the effect was
not as robust as that observed with pretreatment (data not shown).
Our study also provides insight into how Rac1 GTPase
activation contributes to cerebral ischemia pathology, by demon-
strating that Rac1 GTPase activation is critical for induction of
oxidative stress in the hippocampal CA1 region following
ischemia/reperfusion injury. Inhibition of Rac GTPase activation
markedly decreased oxidative neuronal damage to hippocampal
CA1 region lipids, proteins, and DNA following ischemia/
reperfusion injury. The decrease in oxidative stress following
Rac GTPase inhibition is likely due to a correlated significant
attenuation of O2
2 generation, which was observed following
ischemia/reperfusion. Interestingly, targeted inhibition of Rac1
GTPase via a dominant negative approach has been shown to
similarly exert anti-oxidative stress effects against ischemia/
reperfusion injury in the liver [26]. Furthermore, deletion of
Rac1 GTPase in mouse rod photoreceptors via a Cre/Lox
approach has been shown to strongly protect rod photoreceptors
against photo-oxidative stress [27]. Rac1 is also expressed in
endothelium of vascular cells, and targeted deletion of endothelial
Rac1 has been demonstrated to reduce focal cerebral ischemia-
induced edema in mice [28]. Additionally, Kahles and colleagues
have demonstrated that in vivo Rac1 inhibition via administration
of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibi-
tor, atorvastatin, prevented ischemia/reperfusion-induced blood
brain barrier disruption [3]. These findings, coupled with the
results of the current study, support a critical role for Rac1
GTPase activation in the induction of oxidative stress in both
neural and non-neural tissues.
Figure 5. Rac GTPase Activation is Critical for Enhanced
Oxidative Damage in the Hippocampus CA1 Following GCI.
DAB staining of representative coronal CA1 sections show NSC23766
ability to attenuate staining for oxidative stress markers for lipid
peroxidation (4-HNE), DNA damage (8-OHdG) and histone phosphor-
ylation (p-H2A.X). (Four to five animals per treatment group,
magnification used was 20X).
doi:10.1371/journal.pone.0012606.g005
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induction of oxidative stress in the hippocampus by facilitating
activation of NADPH oxidase, a key membrane enzyme that
generates O2
2 ions [6,12,29]. NSC23766 strongly attenuated
NADPH oxidase activation and O2
2 generation in the hippocam-
pal CA1 following GCI, as well as oxidized HEt staining, which is a
marker of in situ O2
2 generation. Moreover, we show that NADPH
oxidase inhibition via the gp91ds-tat NOX2 inhibitor is neuropro-
tective of hippocampus CA1 pyramidal cells at 7 d after ischemia/
reperfusion, further confirming the importance of NADPH oxidase
in neuronal cell death in the hippocampus after global cerebral
ischemia. Studies in phagocytic cells have shown that Rac1 GTPase
plays a key role in activationof the NOX2NADPH oxidase isoform
by a direct binding and recruiting of the p67phox subunit to the
membrane [13,30]. Rac1 GTPase may also be involved in
activation of NOX1 and NOX3 isoforms, but it does not appear
to be involved in activation of the NOX4, NOX 5 or Duox isoforms
[30]. Work by our lab and others has provided evidence that the
NOX2 isoform is a major contributor to O2
2 production and
oxidative stress neuronal damage in the hippocampus and cerebral
cortex following cerebral ischemia, as evidenced by studies using a
competitive NOX2 inhibitor and NOX2 knockout mice [11,12].
Based on these observations, it is proposed that Rac1 GTPase likely
regulates O2
2 generation and oxidative stress in the hippocampus
following GCI through a regulatory action on the NOX2 isoform in
the brain. However, a regulatory effect by Rac1 GTPase on NOX1
and NOX3 in the brain cannot be entirely excluded and deserves
further study.
Figure 6. Effect of the Rac GTPase Inhibitor, NSC23766 Upon Cognitive Function Following GCI. Latency trial (A) and probe trial (B)
results in Morris water maze of non-ischemic control sham and NSC23766 animals showing no effect of NSC23766 in nonischemic control animals.
Panel C shows no significant differences between sham and NSC23766-treated animals in swimming speed (cm/sec); Five animals per condition,
mean 6 SE. (D) Time (sec) spent finding the submerged platform at 7 d, 8 d and 9 d after ischemic injury. (E) Exploration time spent in the quadrant
which initially contained the platform at 9 d following reperfusion. (F) Representative traces indicating the sample paths of the rats from the maze
latency trials (a–d) and the swimming traces from probe trials (e–h) (a, e: sham; b, f: I/R; c, g: vehicle + I/R; d, h: NSC23766 + I/R). Data is expressed as
mean 6 SE from five different animals.*p,0.05 vs. sham,
#p,0.05 vs. vehicle + I/R. I: ischemia; R: reperfusion.
doi:10.1371/journal.pone.0012606.g006
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pathology of cerebral ischemia was further suggested by our
studies using the Morris Water Maze, which revealed preservation
of spatial learning and memory in Rac GTPase inhibitor-treated
animals as compared to vehicle-treated controls at 7–9 days post
ischemia/reperfusion. Swim speed was not different between the
groups, demonstrating that the differences were not due to
differences in locomotor ability or coordination. The Morris
Water Maze is a hippocampal-dependent test of learning and
memory, and thus the enhanced performance of the Rac GTPase
inhibitor-treated animals on the Morris Water Maze is likely
reflective of the attenuation of oxidative stress and enhanced
neuronal survival in the hippocampal CA1 region of NSC23766-
treated rats as compared to vehicle-treated (ischemia) rats.
Mechanistically speaking, NSC23766 has been shown to inhibit
Rac1 binding and activation by preventing interaction of the Rac-
specific guanine exchange factors (GEFs), Trio and Tiam1, with
Rac1 [31]. Thus, it is postulated that regulation of Tiam1 and
Trio following cerebral ischemia contributes to the enhanced Rac1
GTPase activation following ischemia/reperfusion. Additional
studies are needed to address this interesting possibility.
Finally, it is likely that Rac1 GTPase contributes to multiple
pathological events and signaling pathways, which collectively
facilitate neuronal damage and cognitive dysfunction following
cerebral ischemia. For instance, previous work by our group has
shown that Rac1 GTPase also has an important role in activation
of the proapoptotic JNK signaling pathway following cerebral
ischemia, as Rac1 binds to a scaffold complex of POSH and
MLK3 and facilitates activation of JNK [7,32]. Thus, in addition
to enhancing NADPH oxidase activation and oxidative stress
following ischemia/reperfusion, Rac1 also enhances proapototic
JNK signaling, which collectively can enhance oxidative damage
and apoptotic neuronal cell death in the hippocampal CA1 region,
leading to hippocampal dysfunction and cognitive decline.
In conclusion, the current study provides evidence of an
important role of Rac1 GTPase in ischemia/reperfusion injury-
induced NADPH oxidase activation, O2
2 production and
oxidative stress in the hippocampal CA1 region following GCI,
and thereby contributes significantly to the delayed neuronal cell
death and to a negative functional cognitive outcome following
cerebral ischemia. Studies that target Rac1 GTPase for inhibition
may thus have efficacy in preservation of neuronal survival and
cognitive function following stroke in humans, and therefore
should be further explored.
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